Dr. Patricia H. Hardenbergh
Claim this profileShaw Cancer Center
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
42 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage II
Stage I
2Breast Cancer
HER2 positive
HER2 negative
Affiliated Hospitals
Clinical Trials Patricia H. Hardenbergh is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
More about Patricia H. Hardenbergh
Clinical Trial Related7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Patricia H. Hardenbergh has experience with
- Radiation Therapy
- Cisplatin
- Atezolizumab
- Degarelix
- Docetaxel
- Triptorelin
Breakdown of trials Patricia H. Hardenbergh has run
Breast Cancer
Breast cancer
Parotid Gland Cancer
Prostatic Neoplasm
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Patricia H. Hardenbergh specialize in?
Is Patricia H. Hardenbergh currently recruiting for clinical trials?
Are there any treatments that Patricia H. Hardenbergh has studied deeply?
What is the best way to schedule an appointment with Patricia H. Hardenbergh?
What is the office address of Patricia H. Hardenbergh?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.